Skip to main content

Carbatrol

NDC 54092-172 · Takeda Pharmaceuticals America, Inc.

Generic namecarbamazepine
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
Active ingredient(s)CARBAMAZEPINE
Strength200 mg/1
Pharmacologic classCytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
Marketing categoryNDA

Packages

54092-172-12 — 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-172-12)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

51407-896 — Carbamazepine, 51407-897 — Carbamazepine, 51672-4005 — Carbamazepine, 51672-4041 — Carbamazepine, 51672-4047 — Carbamazepine, 51672-4050 — Carbamazepine, 51672-4123 — Carbamazepine, 51672-4124 — Carbamazepine, 51672-4125 — Carbamazepine, 54092-171 — carbamazepine, 54092-173 — carbamazepine, 55154-1396 — Carbamazepine, 59746-789 — Carbamazepine, 59746-790 — Carbamazepine, 59746-791 — Carbamazepine, 60290-008 — Carbamazepine, 60290-034 — Carbamazepine, 60290-058 — Carbamazepine, 60290-059 — Carbamazepine, 60290-060 — Carbamazepine, +134 more

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T42.1X1 — Poisoning by iminostilbenes, accidental (unintentional), T42.1X2 — Poisoning by iminostilbenes, intentional self-harm, T42.1X3 — Poisoning by iminostilbenes, assault, T42.1X4 — Poisoning by iminostilbenes, undetermined, T42.1X5 — Adverse effect of iminostilbenes, T42.1X6 — Underdosing of iminostilbenes